Article
System enhancements may put surgery times closer to standard phaco fordense cataract
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Wilmer Eye Institute marks 100 years: honoring the past, shaping the future
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE
(EyePod) From idea to impact: Navigating ophthalmic innovation
Formosa Pharmaceuticals grants Harrow commercial rights in US to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia
Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis